Is There Still a Role for Succinylcholine in Contemporary Clinical Practice?
暂无分享,去创建一个
[1] A. Møller,et al. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review , 2019, Anaesthesia.
[2] Zhigang Wan,et al. Prolonged neuromuscular block associated with cholinesterase deficiency , 2018, Medicine.
[3] J. Cottrell. Succinylcholine and Intracranial Pressure. , 2018, Anesthesiology.
[4] C. Brown,et al. Emergency Department Intubation Success With Succinylcholine Versus Rocuronium: A National Emergency Airway Registry Study , 2018, Annals of emergency medicine.
[5] J. McCrea,et al. Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial , 2018, British journal of anaesthesia.
[6] H. Nolte,et al. Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non‐anaesthetised volunteers , 2018, British journal of anaesthesia.
[7] C. Bohringer,et al. Is It Time for an Expanded Role of Dexmedetomidine in Contemporary Anesthesia Practice? - A Clinician’s Perspective , 2018, Translational perioperative and pain medicine.
[8] G. Beilman,et al. A Case of Pseudocholinesterase Deficiency Resulting From Malnutrition. , 2016, A & A case reports.
[9] J. Bundgaard,et al. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene , 2016, Pharmacogenetics and genomics.
[10] G. Keating. Sugammadex: A Review of Neuromuscular Blockade Reversal , 2016, Drugs.
[11] I. Oh,et al. Sedation Protocol Using Dexmedetomidine for Third Molar Extraction. , 2016, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[12] T. Takazawa,et al. Sugammadex and rocuronium-induced anaphylaxis , 2015, Journal of Anesthesia.
[13] P. Platt,et al. Efficacy of sugammadex in rocuronium‐induced or antibiotic‐induced anaphylaxis. A case–control study , 2015, Anaesthesia.
[14] M. Demant,et al. Awareness during emergence from anaesthesia: significance of neuromuscular monitoring in patients with butyrylcholinesterase deficiency. , 2015, British journal of anaesthesia.
[15] E. L. Hartley,et al. Rocuronium Versus Suxamethonium: A Survey of First-line Muscle Relaxant Use in UK Prehospital Rapid Sequence Induction , 2015, Prehospital and Disaster Medicine.
[16] J. V. van Schalkwyk,et al. Anaphylaxis Is More Common with Rocuronium and Succinylcholine than with Atracurium , 2015, Anesthesiology.
[17] T. Muñoz-Martínez,et al. [Contraindications to succinylcholine in the intensive care unit. A prevalence study]. , 2015, Medicina intensiva.
[18] T. Hafner,et al. Allergic reaction to suxamethonium during emergency caesarean section and pseudocholinesterase deficiency in the same patient , 2014, Wiener klinische Wochenschrift.
[19] P. Platt,et al. Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia From 2002 to 2011 , 2013 .
[20] T. Mor,et al. Reversal of Succinylcholine Induced Apnea with an Organophosphate Scavenging Recombinant Butyrylcholinesterase , 2013, PloS one.
[21] R. Epstein,et al. Estimate of the Relative Risk of Succinylcholine for Triggering Malignant Hyperthermia , 2013, Anesthesia and analgesia.
[22] A. Cunningham. Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia , 2013 .
[23] P. Diemunsch,et al. Sugammadex in rocuronium anaphylaxis: dose matters. , 2012, British journal of anaesthesia.
[24] T. Yatabe,et al. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. , 2012, Journal of clinical anesthesia.
[25] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[26] D. Hankins. Rocuronium Versus Succinylcholine for Rapid Sequence Intubation , 2012 .
[27] A. Funnell,et al. A further case of rocuronium-induced anaphylaxis treated with sugammadex. , 2011, British journal of anaesthesia.
[28] D. Ebo,et al. Rocuronium‐induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment , 2011, Anaesthesia.
[29] L. Green,et al. Sugammadex in the management of rocuronium-induced anaphylaxis. , 2011, British journal of anaesthesia.
[30] B. Erstad,et al. Comparison of succinylcholine and rocuronium for first-attempt intubation success in the emergency department. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[31] Youn Jin Kim,et al. Lidocaine given intravenously improves conditions for laryngeal mask airway insertion during propofol target-controlled infusion , 2009, European journal of anaesthesiology.
[32] K. Candiotti,et al. Reversal of Profound Neuromuscular Block by Sugammadex Administered Three Minutes after Rocuronium: A Comparison with Spontaneous Recovery from Succinylcholine , 2009, Anesthesiology.
[33] T. Han,et al. Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus. , 2009, British journal of anaesthesia.
[34] I. Looi,et al. Anaesthetists' nightmare: masseter spasm after induction in an undiagnosed case of myotonia congenita. , 2008, The Medical journal of Malaysia.
[35] J. Perry,et al. Rocuronium versus succinylcholine for rapid sequence induction intubation. , 2008, The Cochrane database of systematic reviews.
[36] M. Klimek,et al. Reversal of Rocuronium-induced (1.2 mg/kg) Profound Neuromuscular Block by Sugammadex: A Multicenter, Dose-finding and Safety Study , 2007, Anesthesiology.
[37] M. Galinski,et al. Stability of succinylcholine solutions stored at room temperature studied by nuclear magnetic resonance spectroscopy , 2007, Emergency Medicine Journal.
[38] E. Chidiac,et al. Succinylcholine and the open eye. , 2006, Ophthalmology clinics of North America.
[39] J. Martyn,et al. Succinylcholine-induced Hyperkalemia in Acquired Pathologic States: Etiologic Factors and Molecular Mechanisms , 2006, Anesthesiology.
[40] K. Guenterberg,et al. Masseter spasm after succinylcholine administration. , 2005, The Journal of emergency medicine.
[41] B. Adams,et al. Succinylcholine induced masseter spasm during rapid sequence intubation may require a surgical airway: case report , 2005, Emergency Medicine Journal.
[42] T. Raghavendra. Neuromuscular blocking drugs: discovery and development. , 2002, Journal of the Royal Society of Medicine.
[43] F. Dexter,et al. Cost Identification Analysis for Succinylcholine , 2001, Anesthesia and analgesia.
[44] J. Biehl. Military and civilian penetrating eye trauma: anesthetic implications. , 2001, AANA journal.
[45] P. Hopkins,et al. Suxamethonium and mivacurium sensitivity from pregnancy‐induced plasma cholinesterase deficiency , 1998, Anaesthesia.
[46] M. Fox,et al. Prolonged neuromuscular block associated with mivacurium. , 1996, British journal of anaesthesia.
[47] Chingmuh Lee. Suxamethonium in its fifth decade , 1994 .
[48] J. Lerman,et al. Succinylcholine warning , 1994, Canadian Journal of Anaesthesia-journal Canadien D Anesthesie.
[49] Ronald D. Miller,et al. Comparison of Rocuronium, Succinylcholine, and Vecuronium for Rapid‐sequence Induction of Anesthesia in Adult Patients , 1993, Anesthesiology.
[50] A. Onitsuka,et al. [Succinylcholine neuromuscular blockade in a case of pseudocholinesterase variant]. , 1989, Masui. The Japanese journal of anesthesiology.
[51] E. Azevêdo,et al. Frequencies of atypical serum cholinesterase in a mixed population of northeastern Brazil. , 1984, Human heredity.
[52] L. Homer,et al. Onset of Succinylcholine‐induced Hyperkalemia Following Denervation , 1976, Anesthesiology.
[53] A. Baraka,et al. Control of succinylcholine-induced myotonia by d-tubocurarine. , 1970, Anesthesiology.
[54] F. Foldes,et al. Succinylcholine: a new approach to muscular relaxation in anesthesiology. , 1952, The New England journal of medicine.